Molecular Treatment of Metabolic Associated Fatty Liver Disease/Nonalcoholic Fatty Liver Disease
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 317
Special Issue Editors
Interests: bioactive peptides; natural products; stem cells; skin; wound healing; nonalcoholic fatty liver disease/metabolic associated fatty liver disease; diabetes; cancer
Interests: mesoporous materials; in-situ characterisation; biomass conversion; biomaterials; renewables
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
With an increasing sedentary lifestyle and overeating, more than one-quarter of people worldwide are suffering from nonalcoholic fatty liver disease (NAFLD). NAFLD can progress to nonalcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma and is associated with extrahepatic complications such as cardiovascular disease, metabolic syndrome, and renal disease. Metabolic associated fatty liver disease (MAFLD) was suggested as a more appropriate term for NAFLD by a panel of international experts from 22 countries in 2020, with an update of the disease definition. Currently, no molecular treatment is approved for MAFLD/NAFLD specifically, and lifestyle intervention is the main treatment strategy.
This Special Issue, entitled “Molecular Treatment of Metabolic Associated Fatty Liver Disease/Nonalcoholic Fatty Liver Disease”, is planned to gather scientific papers on a wide range of topics including (but not limited to) peptides, natural products, foods, biomaterials for the treatment of MAFLD/NAFLD and its complications, as well as the underlying mechanisms and therapeutic targets discovery. This Special Issue invites researchers to contribute original research articles of their recent work and reviews regarding recent advances on the molecular treatment of MAFLD/NAFLD and its complications.
Dr. Dianbao Zhang
Dr. Volkan Degirmenci
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metabolic associated fatty liver disease (MAFLD)
- nonalcoholic fatty liver disease (NAFLD)
- complications
- peptides
- natural products
- foods
- biomaterials
- mechanisms
